FOLH1 and prostate cancer: GCPII/PSMA levels in plasma can serve as an early diagnostic of prostate cancer, as GCPII in the prostate is endocytosed from the extracellular space into endosomes, which fuse with multivesicular bodies to form and secrete exosomes [15, 16].